Biontech has been a great steady performer all year. recently, they partnered with Pfizer to make a new vaccine what is being implemented in UK. My concern for this is now, they have shown their cards. The vaccine has been in the news for nearly 2 months. Have those gains been realized already I ask myself. I may look else where for more solid ideas, or may take a very modest position if BIONTECH trends on the base line of this trend, showing some divergence.
ความคิดเห็น
⋅
I'll be a buyer at $82
ความคิดเห็น
⋅
So, it's at $81.95. Looking at options 2 months out. Would like to see a form of capitulation before moving in though